| Online-Ressource |
Verfasst von: | Tscheschner, Henrike [VerfasserIn]  |
| Meinhardt, Eric [VerfasserIn]  |
| Schlegel, Philipp [VerfasserIn]  |
| Jungmann, Andreas [VerfasserIn]  |
| Lehmann, Lorenz [VerfasserIn]  |
| Müller, Oliver J. [VerfasserIn]  |
| Most, Patrick [VerfasserIn]  |
| Katus, Hugo [VerfasserIn]  |
| Raake, Philip [VerfasserIn]  |
Titel: | CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression |
Verf.angabe: | Henrike Tscheschner, Eric Meinhardt, Philipp Schlegel, Andreas Jungmann, Lorenz H. Lehmann, Oliver J. Müller, Patrick Most, Hugo A. Katus, Philip W. Raake |
E-Jahr: | 2019 |
Jahr: | April 29, 2019 |
Umfang: | 20 S. |
Fussnoten: | Gesehen am 27.05.2019 |
Titel Quelle: | Enthalten in: PLOS ONE |
Ort Quelle: | San Francisco, California, US : PLOS, 2006 |
Jahr Quelle: | 2019 |
Band/Heft Quelle: | 14(2019), 4, Artikel-ID e0215992, Seite 1-20 |
ISSN Quelle: | 1932-6203 |
Abstract: | The clinical use of the chemotherapeutic doxorubicin (Dox) is limited by cardiotoxic side-effects. One of the early Dox effects is induction of a sarcoplasmic reticulum (SR) Ca2+ leak. The chaperone Glucose regulated protein 78 (GRP78) is important for Ca2+ homeostasis in the endoplasmic reticulum (ER)—the organelle corresponding to the SR in non-cardiomyocytes—and has been shown to convey resistance to Dox in certain tumors. Our aim was to investigate the effect of cardiac GRP78 gene transfer on Ca2+ dependent signaling, cell death, cardiac function and survival in clinically relevant in vitro and in vivo models for Dox cardiotoxicity.By using neonatal cardiomyocytes we could demonstrate that Dox induced Ca2+ dependent Ca2+ /calmodulin-dependent protein kinase II (CaMKII) activation is one of the factors involved in Dox cardiotoxicity by promoting apoptosis. Furthermore, we found that adeno-associated virus (AAV) mediated GRP78 overexpression partly protects neonatal cardiomyocytes from Dox induced cell death by modulating Ca2+ dependent pathways like the activation of CaMKII, phospholamban (PLN) and p53 accumulation. Most importantly, cardiac GRP78 gene therapy in mice treated with Dox revealed improved diastolic function (dP/dtmin) and survival after Dox treatment. In conclusion, our results demonstrate for the first time that Ca2+ dependent CaMKII activation fosters Dox cardiomyopathy and provide additional insight into possible mechanisms by which GRP78 overexpression protects cardiomyocytes from Doxorubicin toxicity. |
DOI: | doi:10.1371/journal.pone.0215992 |
URL: | kostenfrei: Volltext: https://doi.org/10.1371/journal.pone.0215992 |
| kostenfrei: Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0215992 |
| DOI: https://doi.org/10.1371/journal.pone.0215992 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Apoptosis |
| Cancer treatment |
| Cardiomyocytes |
| Cardiovascular physiology |
| Hyperexpression techniques |
| Immunoblotting |
| Luciferase |
| Phosphorylation |
K10plus-PPN: | 1666356255 |
Verknüpfungen: | → Zeitschrift |
|
|
| |
Lokale URL UB: | Zum Volltext |
CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression / Tscheschner, Henrike [VerfasserIn]; April 29, 2019 (Online-Ressource)